Literature DB >> 20188857

New insights into acute lung injury.

Stephen M Black1.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20188857      PMCID: PMC2862586          DOI: 10.1016/j.vph.2010.02.002

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


× No keyword cloud information.
  45 in total

Review 1.  P2 purinergic receptors: modulation of cell function and therapeutic potential.

Authors:  G Burnstock; M Williams
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

Review 2.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

3.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 4.  Pathophysiology of sepsis.

Authors:  Judith Jacobi
Journal:  Am J Health Syst Pharm       Date:  2002-02-15       Impact factor: 2.637

5.  Shear stress-mediated cytoskeletal remodeling and cortactin translocation in pulmonary endothelial cells.

Authors:  Konstantin G Birukov; Anna A Birukova; Steven M Dudek; Alexander D Verin; Michael T Crow; Xi Zhan; Natacha DePaola; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2002-04       Impact factor: 6.914

6.  Adenosine formed by 5'-nucleotidase mediates tubuloglomerular feedback.

Authors:  S Thomson; D Bao; A Deng; V Vallon
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

7.  E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators.

Authors:  D C Angus; M C Birmingham; R A Balk; P J Scannon; D Collins; J A Kruse; D R Graham; H V Dedhia; S Homann; N MacIntyre
Journal:  JAMA       Date:  2000-04-05       Impact factor: 56.272

8.  A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.

Authors:  D Annane; V Sébille; G Troché; J C Raphaël; P Gajdos; E Bellissant
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

9.  Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

Authors:  E Abraham; K Reinhart; P Svoboda; A Seibert; D Olthoff; A Dal Nogare; R Postier; G Hempelmann; T Butler; E Martin; C Zwingelstein; S Percell; V Shu; A Leighton; A A Creasey
Journal:  Crit Care Med       Date:  2001-11       Impact factor: 7.598

10.  Inhibition of the phosphatase PTEN protects mice against oleic acid-induced acute lung injury.

Authors:  Ju-Ping Lai; Shengying Bao; Ian C Davis; Daren L Knoell
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

View more
  2 in total

Review 1.  Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury.

Authors:  L J Mark Cross; Michael A Matthay
Journal:  Crit Care Clin       Date:  2011-04       Impact factor: 3.598

Review 2.  The Role of Oxidative Stress in Sarcoidosis.

Authors:  Sara Solveig Fois; Sara Canu; Alessandro Giuseppe Fois
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.